Veterinary Medicines

FATROXIMIN 300 mg/4g πεσσός, για αγελάδες, βουβάλες και φορβάδες που δεν προορίζονται για ανθρώπινη κατανάλωση

Authorised
  • Rifaximin
Download as PDF

Product identification

Medicine name:
FATROXIMIN 300 mg/4g πεσσός, για αγελάδες, βουβάλες και φορβάδες που δεν προορίζονται για ανθρώπινη κατανάλωση
Active substance:
  • Rifaximin
Target species:
  • Cattle (cow)
  • Buffalo (female)
  • Horse (mare)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Rifaximin
    0.30
    gram(s)
    /
    1.00
    Pessary
Pharmaceutical form:
  • Pessary
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Buffalo (female)
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06AX11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 65433/14-09-2012/K-0036501
Date of authorisation status change: